ABBV logoABBV
Abbvie Inc

31,995
Loading...
Loading...
News
all
press releases
Company News for Oct 1, 2025
Companies in The News Are: LW, UNFI, PRGS, ABBV
Zacks·18h ago
News Placeholder
More News
News Placeholder
AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment Options
AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment Options...
PR Newswire·2d ago
News Placeholder
AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease
ABBV files for FDA approval of tavapadon, a once-daily oral Parkinson's drug backed by late-stage TEMPO studies.
Zacks·3d ago
News Placeholder
Has AbbVie Successfully Navigated Top-line Growth Post Humira LOE?
ABBV eyes a 2025 rebound as Skyrizi and Rinvoq drive growth beyond Humira, with oncology and neuroscience adding momentum.
Zacks·6d ago
News Placeholder
Pharmaceutical Tariffs ‘A Light At The End Of The Trump Tunnel’ For Big Pharma, Says Jefferies
The analyst noted that several large-cap pharmaceutical companies have already announced plans to build U.S. manufacturing facilities.
Stocktwits·6d ago
News Placeholder
AbbVie (ABBV) Declines More Than Market: Some Information for Investors
AbbVie (ABBV) concluded the recent trading session at $219.99, signifying a -1.18% move from its prior day's close.
Zacks·7d ago
News Placeholder
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum.
Zacks·13d ago
News Placeholder
The Zacks Analyst Blog Highlights AbbVie, ServiceNow, Boeing, Tucows and and Ampco-Pittsburgh
Zacks spotlights AbbVie, ServiceNow, Boeing, Tucows, and Ampco-Pittsburgh, detailing growth drivers, headwinds, and industry positioning.
Zacks·13d ago
News Placeholder
Top Analyst Reports for AbbVie, ServiceNow & Boeing
AbbVie, ServiceNow, and Boeing outpace their industries as analysts highlight growth drivers and risks in fresh research reports.
Zacks·13d ago
News Placeholder
J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why
J&J sees Innovative Medicines growth in 2025, fueled by oncology and immunology drugs, despite steep Stelara sales erosion.
Zacks·14d ago

Latest ABBV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.